NAPHCON-A Drug Patent Profile
✉ Email this page to a colleague
When do Naphcon-a patents expire, and what generic alternatives are available?
Naphcon-a is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in NAPHCON-A is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Naphcon-a
A generic version of NAPHCON-A was approved as naphazoline hydrochloride; pheniramine maleate by ALTAIRE PHARMS INC on September 27th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NAPHCON-A?
- What are the global sales for NAPHCON-A?
- What is Average Wholesale Price for NAPHCON-A?
Summary for NAPHCON-A
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| DailyMed Link: | NAPHCON-A at DailyMed |
US Patents and Regulatory Information for NAPHCON-A
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | NAPHCON-A | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 020226-001 | Jun 8, 1994 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
